CTRI/2016/03/006744
Completed
未知
A prospective open label clinical study to evaluate the safety and efficacy of Bio-Iron tablets for Iron repletion in adult male or female patients suffering with Iron deficiency anaemia.
Sami Labs Limited0 sites30 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sami Labs Limited
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Male \& female outpatients between 18 to 55 years.
- •2 Presence of iron deficiency anaemia:below normal or low haemoglobin.
- •3 Using effective method of contraception if sexually active.
- •4 Willing to come for regular follow\-up visits.
- •5 Able to give written informed consent.
- •6 Non\-use of any iron supplement for 2 weeks prior to enrolment to the study and to know the dosage timing of Calcium supplement if any.
- •7 Able to comply with the requirements of the Protocol.
Exclusion Criteria
- •1 Known history of hypersensitivity to herbal extracts or dietary supplements.
- •2 Pregnant women, lactating women and women of child bearing potential not following adequate contraceptive measure, women who were found positive for urine pregnancy test.
- •3 Medical history of current haematological disorders other than iron deficiency anaemia (e.g. aplastic anaemia, megaloblastic anaemia, sideroblastic anaemia, pernicious anaemia, thalassemia, sickle cell anaemia, etc.).
- •4 Medical history of chronic renal disease.
- •5 Medical history of malabsorption syndrome, hemochromatosis.
- •6 Obvious internal or external bleeding as documented by medical history.
- •7 Medical history of hepatitis B, hepatitis C and/or exposure to HIV.
- •8 Participation in another clinical trial in the last 8 weeks before entry to Visit 0\.
- •9 Evidence of alcohol or drug abuse, that may, in the opinion of the Investigator interferes with study compliance or prevents understanding of the objectives, investigational procedures or possible consequences of the study.
- •10 Known or suspected hypersensitivity to iron or any of the components of Investigational Product.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Effect of a herbal soap on skin moisture enhancementCTRI/2019/03/018137Ramaiah Indic Specialty Ayurveda Restoration Hospital50
Completed
Not Applicable
Clinical trial of Amla Extract in subjects with abnormal cholesterol levels.CTRI/2017/02/007829Arjuna Natural Extracts Ltd39
Recruiting
Phase 1
To evaluate the safety and efficacy of R-HSC-001 in patients withParkinsons Disease (Neurological disease)CTRI/2009/091/000667Reliance Life Science Pvt Ltd10
Not yet recruiting
Not Applicable
This is a clinical trial wherein the efficacy and safety of Hair serum will be studied on Hair Growth and Hair Fall in healthy adult humans.CTRI/2016/06/007061Sami Labs Limited40
Not yet recruiting
Phase 3
Clinical Study on Beta Glucan on Patients with PsoriasisCTRI/2023/05/053308ichi-In Bio Sciences Pvt. Ltd